GLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History
Open access0 citations
Abstract
This cross-sectional study examines how use of glucagon-like peptide-1 (GLP-1) receptor agonists varies among US adults with diabetes with or without a history of cancer.
// Source
Authors: Olinto Linares-Perdomo, Damon Klebe, Fumiko Chino, Bismarck C.L. Odei
Institutions: The University of Texas MD Anderson Cancer Center, Huntsman Cancer Institute